Dupont Capital Management Corp Albireo Pharma, Inc. Transaction History

Dupont Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$28.9 - $36.87 $187,503 - $239,212	-6,488 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$32.03 - $42.85 $42,631 - $57,033	-1,331 Reduced 17.02%	6,488 $229,000
Q4 2020 Jan 28, 2021	SELL	$31.56 - $42.16 $18,431 - $24,621	-584 Reduced 6.95%	7,819 $293,000
Q3 2020 Oct 29, 2020	SELL	$23.19 - $41.61 $13,055 - $23,426	-563 Reduced 6.28%	8,403 $280,000
Q2 2020 Jul 24, 2020	BUY	$14.82 - $29.92 $132,876 - $268,262	8,966 New	8,966 $238,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.